These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia. Awidi A, Maqablah A, Dweik M, Bsoul N, Abu-Khader A. Platelets; 2009 Aug; 20(5):297-301. PubMed ID: 19548178 [Abstract] [Full Text] [Related]
3. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function. Ghosh K, Nair S, Kulkarni B, Khare A, Shetty S, Mohanty D. Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548 [Abstract] [Full Text] [Related]
4. Bernard-Soulier-like functional platelet defect in myelodysplastic syndrome and in acute myeloblastic leukemia associated with trilineage myelodysplasia. Hiçsönmez G, Gümrük F, Cetin M, Ozbek N, Tuncer M, Gürsel T. Turk J Pediatr; 1995 Sep; 37(4):425-9. PubMed ID: 8560614 [Abstract] [Full Text] [Related]
5. Platelet function in the myelodysplastic syndromes. Mittelman M, Zeidman A. Int J Hematol; 2000 Feb; 71(2):95-8. PubMed ID: 10745619 [Abstract] [Full Text] [Related]
6. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)]. Shenkman B, Einav Y, Salomon O, Varon D, Savion N. Platelets; 2008 Sep; 19(6):440-6. PubMed ID: 18925512 [Abstract] [Full Text] [Related]
7. Platelet function and its clinical significance in the myelodysplastic syndromes. Zeidman A, Sokolover N, Fradin Z, Cohen A, Redlich O, Mittelman M. Hematol J; 2004 Sep; 5(3):234-8. PubMed ID: 15167910 [Abstract] [Full Text] [Related]
8. Platelet refractoriness to classical agonists in a child with essential thrombocythemia. Jaime-Perez JC, Gomez-Almaguer D. Platelets; 2005 Feb; 16(1):61-2. PubMed ID: 15763898 [Abstract] [Full Text] [Related]
9. Essential athrombia: study of a new case. Inceman S, Tangün Y. Thromb Diath Haemorrh; 1975 Apr 30; 33(2):278-85. PubMed ID: 1138423 [Abstract] [Full Text] [Related]
10. Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload. Popov VM, Vladareanu AM, Bumbea H, Kovacs E, Savopol T, Iordache MM, Moisescu MG. Blood Coagul Fibrinolysis; 2015 Oct 30; 26(7):743-9. PubMed ID: 25811447 [Abstract] [Full Text] [Related]
11. The Hermansky-Pudlak syndrome. Evidence for a lowered 5-hydroxytryptamine content in platelets of heterozygotes. Gerritsen SM, Akkerman JW, Nijmeijer B, Sixma JJ, Witkop CJ, White J. Scand J Haematol; 1977 Mar 30; 18(3):249-56. PubMed ID: 847398 [Abstract] [Full Text] [Related]
12. Platelet aggregation responses vary over a period of time in healthy controls. Refaai MA, Frenkel E, Sarode R. Platelets; 2010 Mar 30; 21(6):460-3. PubMed ID: 20536288 [Abstract] [Full Text] [Related]
13. Reproducibility of platelet function testing. Hevelow ME, McKenzie SM, Siegel JE. Lab Hematol; 2007 Mar 30; 13(2):59-62. PubMed ID: 17573283 [Abstract] [Full Text] [Related]
14. Studies on platelet aggregation using the Born method in normal and uraemic dogs. Mischke R, Schulze U. Vet J; 2004 Nov 30; 168(3):270-5. PubMed ID: 15501144 [Abstract] [Full Text] [Related]
15. Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities. Milton JG, Hutton RA, Tuddenham EG, Frojmovic MM. J Lab Clin Med; 1985 Sep 30; 106(3):326-35. PubMed ID: 4031633 [Abstract] [Full Text] [Related]
16. [Determination of platelet aggregation using the KZM-1-R meter (aggregation inducers: ADP, collagen, ristocetin, ristomycin, adrenaline. Therapy control by use of acetylsalicylic acid)]. Stepanauskas M, Norden C, Söllner P, Heine H. Z Med Lab Diagn; 1981 Sep 30; 22(3):148-54. PubMed ID: 6270924 [No Abstract] [Full Text] [Related]
17. Hemorrhagic tendency in beta-thalassemia major. Eldor A. Isr J Med Sci; 1978 Nov 30; 14(11):1132-4. PubMed ID: 750538 [Abstract] [Full Text] [Related]
18. Influence of storage temperature on the responsiveness of human platelets to agonists. Choi JW, Pai SH. Ann Clin Lab Sci; 2003 Nov 30; 33(1):79-85. PubMed ID: 12661901 [Abstract] [Full Text] [Related]
19. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes. Martín M, de Paz R, Jiménez-Yuste V, Fernández Bello I, García Arias Salgado E, Alvarez MT, Butta NV. Thromb Haemost; 2013 May 30; 109(5):909-19. PubMed ID: 23407717 [Abstract] [Full Text] [Related]
20. [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis]. Thommen D, Sulzer I, Buhrfeind E, Naef R, Furlan M, Lämmle B. Schweiz Med Wochenschr; 1988 Oct 29; 118(43):1559-67. PubMed ID: 3238391 [Abstract] [Full Text] [Related] Page: [Next] [New Search]